Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

UN Targets on Health Risk Factors can Prevent 37 Million Deaths by 2025

Published: Tuesday, May 13, 2014
Last Updated: Tuesday, May 13, 2014
Bookmark and Share
Reaching globally-agreed targets for health risks such as smoking and alcohol can prevent more than 37 million deaths by 2025.

A new international study led by Imperial College London has estimated how achieving globally-agreed targets for six important health risks between 2010 and 2025 will reduce deaths caused by the big-four chronic diseases: cancers, diabetes, lung disease and cardiovascular disease (mainly heart disease and stroke).

Published in The Lancet the study finds that achieving the targets can prevent over 37 million deaths from these diseases by 2025. The large majority of the extra deaths will be in low-to-middle-income nations. Targets for reducing smoking and blood pressure will lead to the largest health benefits.

In 2011, the UN General Assembly agreed to reduce deaths from the big-four chronic diseases. The World Health Organization (WHO) created targets for both premature deaths from these chronic diseases and their key risk factors like smoking, alcohol use, high blood pressure and blood glucose, obesity and salt consumption. The researchers analyzed the effects of achieving these targets for risk factor on deaths from the four major chronic diseases.

The study shows that the big-four chronic diseases killed over 28 million people in 2010, a number that is projected to increase to 39 million in 2025 if no new action is taken.

If the six risk factor targets are achieved, the risk of dying prematurely from chronic diseases in 2025 will go down by 22 per cent for men and by 19 per cent for women compared to their 2010 levels. This corresponds to preventing more than 37 million deaths between 2010 and 2025, including 16 million deaths amongst those who are younger than 70 years and whose deaths are considered premature.

Senior author of the study, Professor Majid Ezzati from the MRC-PHE Centre for Environment at Imperial College London's School of Public Health said: "It is possible to achieve most of the desired reduction in deaths from chronic diseases by tackling a small number of preventable risk factors."

The current global targets include a 30 per cent reduction in smoking levels, a 10 per cent reduction in alcohol consumption and a 30 per cent reduction in salt in food.

The research found that achievement of some targets had bigger impacts than others, with reductions in smoking and blood pressure producing the greatest benefits.

If a more ambitious target of halving the levels of smoking is achieved alongside the other targets, the risk of dying prematurely from the big-four would be reduced by nearly 25 per cent in men - the desired global target - and by 20 per cent in women. This corresponds to averting nearly 43 million deaths between 2010 and 2025.

Study lead author, Dr Vasilis Kontis from Imperial College London's School of Public Health said: "Our study demonstrates that the tobacco use target should be more ambitious. Reducing the prevalence of smoking by 50 per cent by 2025 is feasible based on proven policy measures, and should become a global target to avoid millions of premature deaths."

Professor Ezzati said: "Much larger impacts will be seen in low-to-middle-income countries where 31 million deaths will be averted. High income countries are already working towards many of these targets with a range of policy measures such as tobacco and alcohol taxes, public smoking bans, and guidelines to reduce the amount of salt in food, although we still need to find ways to curb obesity and diabetes.

"Our study shows the urgent need for a greater policy push and injection of resources into low-to-middle-income countries to replicate the success stories and to avoid escalating numbers of chronic disease deaths in the poorest countries," he added.

The study also showed that the risk factor targets had different impacts depending on the disease. The greatest impact was on cardiovascular disease and chronic lung disease, with more than a 25 per cent reduction in the risk of premature death from each of these conditions. Importantly, achieving the risk factor targets will also reverse the rising tide of mortality from diabetes.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More Than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

New Technique Negotiates Neuron Jungle To Target Source Of Parkinson’s Disease
Researchers from Imperial College London and Newcastle University believe they have found a potential new way to target cells of the brain affected by Parkinson’s disease.
Wednesday, September 23, 2015
Designer Molecule Shines a Spotlight on Mysterious Four-Stranded DNA
A small fluorescent molecule has shed new light on knots of DNA thought to play a role in regulating how genes are switched on and off.
Thursday, September 10, 2015
Highly Effective Seasickness Treatment on the Horizon
The misery of motion sickness could be ended within five to ten years thanks to a new treatment being developed by scientists.
Monday, September 07, 2015
Health Risks of Saturated Fats Aggravated by Immune Response
Research shows that the presence of saturated fats resulted in monocytes migrating into the tissues of vital organs.
Friday, September 04, 2015
Discovery of Trigger for Bugs’ Defences Could Lead to New Antibiotics
New research shows that sigma54 holds a bacterium’s defences back until it encounters stress.
Friday, August 21, 2015
Breakthrough Could Lead to New Antibiotics
Scientists have exposed a chink in the armour of disease-causing bugs, with a new discovery about a protein that controls bacterial defences.
Friday, August 21, 2015
New Drug Target Identified for Serious Heart and Lung Condition
A gene has been identified that sheds new light on a potentially fatal heart and lung condition and could lead to a new treatment.
Friday, August 14, 2015
Study Finds Brain Chemicals that Keep Wakefulness in Check
Researchers to develop new drugs that promote better sleep, or control hyperactivity in people with mania.
Saturday, August 01, 2015
Fossil Fuel Emissions will Complicate Radiocarbon Dating, Warns Scientist
The paper is published in the journal PNAS.
Tuesday, July 21, 2015
Scientists Find New Variant of Streptococcal Bacteria Causing Severe Infections
Researchers noticed a sharp rise in infections caused by emm89.
Wednesday, July 15, 2015
Gene Therapy for Cystic Fibrosis Shows Encouraging Trial Results
A therapy that replaces the faulty gene responsible for cystic fibrosis in patients' lungs has produced encouraging results in a major UK trial.
Friday, July 03, 2015
New Genetic Form of Obesity and Diabetes Discovered
Scientists have discovered a new inherited form of obesity and type 2 diabetes in humans.
Tuesday, June 30, 2015
New Genetic Form of Obesity and Diabetes Discovered
Scientists have discovered a new inherited form of obesity and type 2 diabetes in humans.
Tuesday, June 30, 2015
Researchers Develop New Breath Test to Diagnose Oesophageal and Gastric Cancer
Test will now be tested in a larger trial involving three hospitals in London.
Tuesday, June 23, 2015
'Crumpled' Filter to Slash Energy Consumption
Scientists have developed an ultra-thin, super-strong membrane to filter liquids and gases, with the potential to cut energy consumption in industry.
Friday, June 19, 2015
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Promising Drug Combination for Advanced Prostate Cancer
A new drug combination may be effective in treating men with metastatic prostate cancer. Preliminary results of this new approach are encouraging and have led to an ongoing international study being conducted in 196 hospitals worldwide.
A Cellular Symphony Responsible for Autoimmune Disease
Broad Institute researchers have used a novel approach to increase our understanding of the immune system as a whole.
When it Comes to Breast Cancer, Common Pigeon is No Bird Brain
If pigeons went to medical school and specialized in pathology or radiology, they’d be pretty good at distinguishing digitized microscope slides and mammograms of normal vs. cancerous breast tissue, a new study has found.
Editing of LIMS Data Made Faster and More Efficient in Matrix Gemini
The latest version of the Matrix Gemini LIMS (Laboratory Information Management System) from Autoscribe Informatics now provides faster and more efficient editing of LIMS data by eliminating the need for a second editing screen.
University of Edinburgh, Selcia Achieve Key Milestones in Drug Development Program
Scientists from the University of Edinburgh, working with Selcia, have successfully passed the 20-month milestone targets of a 30-month Wellcome Trust SDDi £2.5 million project to design novel treatments for sleeping sickness.
Red Clover Genome to Help Restore Sustainable Farming
The Genome Analysis Centre (TGAC) in collaboration with IBERS, has sequenced and assembled the DNA of red clover to help breeders improve the beneficial traits of this important forage crop.
How a Genetic Locus Protects Adult Blood-Forming Stem Cells
Mammalian imprinted Gtl2 protects adult hematopoietic stem cells by restricting metabolic activity in the cells' mitochondria.
Genetic Basis of Fatal Flu Side Effect Discovered
A group of people with fatal H1N1 flu died after their viral infections triggered a deadly hyperinflammatory disorder in susceptible individuals with gene mutations linked to the overactive immune response, according to a recent study.
New Tech Vastly Improves CRISPR/Cas9 Accuracy
A new CRISPR/Cas9 technology developed by scientists at UMass Medical School is precise enough to surgically edit DNA at nearly any genomic location, while avoiding potentially harmful off-target changes typically seen in standard CRISPR gene editing techniques.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos